Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts
Ari Ahola‐Olli, Linda Mustelin, Maria Kalimeri, et al.
Diabetologia (2019) Vol. 62, Iss. 12, pp. 2298-2309
Open Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Metabolomic profiles predict individual multidisease outcomes
Thore Buergel, Jakob Steinfeldt, Greg Ruyoga, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2309-2320
Open Access | Times Cited: 218
Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies
Jakub Morze, Clemens Wittenbecher, Lukas Schwingshackl, et al.
Diabetes Care (2022) Vol. 45, Iss. 4, pp. 1013-1024
Open Access | Times Cited: 170
Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Qiao Jin, Ronald C.W.
Cells (2021) Vol. 10, Iss. 11, pp. 2832-2832
Open Access | Times Cited: 159
Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
Heli Julkunen, Anna Cichońska, P. Eline Slagboom, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 157
Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus
Margarita Ortiz‐Martínez, Mirna González‐González, Alexandro J. Martagón, et al.
Current Diabetes Reports (2022) Vol. 22, Iss. 3, pp. 95-115
Open Access | Times Cited: 109
Applications of machine learning in metabolomics: Disease modeling and classification
Aya Galal, Marwa Talal, Ahmed A. Moustafa
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 84
Genome-wide characterization of circulating metabolic biomarkers
Minna K. Karjalainen, Savita Karthikeyan, Clare Oliver‐Williams, et al.
Nature (2024) Vol. 628, Iss. 8006, pp. 130-138
Open Access | Times Cited: 79
Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study
Fiona Bragg, Eirini Trichia, Diego Aguilar‐Ramirez, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72
Association of Combined Exposure to Ambient Air Pollutants, Genetic Risk, and Incident Rheumatoid Arthritis: A Prospective Cohort Study in the UK Biobank
Jie Zhang, Xinyu Fang, Jun Wu, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 3
Open Access | Times Cited: 50
Metabolomics and Proteomics in Type 2 Diabetes
Zsu‐Zsu Chen, Robert E. Gerszten
Circulation Research (2020) Vol. 126, Iss. 11, pp. 1613-1627
Open Access | Times Cited: 125
Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug–metabolite atlas
Jun Liu, Lies Lahousse, Michel G. Nivard, et al.
Nature Medicine (2020) Vol. 26, Iss. 1, pp. 110-117
Closed Access | Times Cited: 72
Prediction of type 2 diabetes using genome-wide polygenic risk score and metabolic profiles: A machine learning analysis of population-based 10-year prospective cohort study
Seok-Ju Hahn, Suhyeon Kim, Young Sik Choi, et al.
EBioMedicine (2022) Vol. 86, pp. 104383-104383
Open Access | Times Cited: 46
PPM1K-regulated impaired catabolism of branched-chain amino acids orchestrates polycystic ovary syndrome
Liangshan Mu, Zhenhong Ye, Junhao Hu, et al.
EBioMedicine (2023) Vol. 89, pp. 104492-104492
Open Access | Times Cited: 27
Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study
Madeleine L. Smith, Caroline J. Bull, Michael V. Holmes, et al.
EBioMedicine (2023) Vol. 90, pp. 104503-104503
Open Access | Times Cited: 25
Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts
Habtamu B. Beyene, Corey Giles, Kevin Huynh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Cordyceps militaris extracts and cordycepin ameliorate type 2 diabetes mellitus by modulating the gut microbiota and metabolites
Xinyuan Liu, Mengqian Dun, Tongtong Jian, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
A two-sample Mendelian randomization study explores metabolic profiling of different glycemic traits
Tommy Hon Ting Wong, J. Mo, Mingqi Zhou, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 9
Exploring machine learning strategies for predicting cardiovascular disease risk factors from multi-omic data
Gabin Drouard, Juha Mykkänen, Jarkko S. Heiskanen, et al.
BMC Medical Informatics and Decision Making (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Heterogeneously elevated branched-chain/aromatic amino acids among new-onset type-2 diabetes mellitus patients are potentially skewed diabetes predictors
Min Wang, Yang Ou, Xiang-Lian Yuan, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 1, pp. 53-71
Open Access | Times Cited: 8
Development and External Validation of Machine Learning Models for Diabetic Microvascular Complications: Cross-Sectional Study With Metabolites
Feng He, Clarissa Ng Yin Ling, Simon Nusinovici, et al.
Journal of Medical Internet Research (2024) Vol. 26, pp. e41065-e41065
Open Access | Times Cited: 8
Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus
Xinyun Gu, Mohammed Al Dubayee, Awad Alshahrani, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 60
Dietary Intake of Linoleic Acid, Its Concentrations, and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies
Seyed Mohammad Mousavi, Yahya Jalilpiran‬, Elmira Karimi, et al.
Diabetes Care (2021) Vol. 44, Iss. 9, pp. 2173-2181
Open Access | Times Cited: 53
Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
Qing Fang, Na Liu, Binjie Zheng, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 47
Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts
Emmi Tikkanen, Vilma Jägerroos, Michael V. Holmes, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 23
Open Access | Times Cited: 45
Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes
Stefan Mutter, Erkka Valo, Viljami Aittomäki, et al.
Diabetologia (2021) Vol. 65, Iss. 1, pp. 140-149
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top